Rentokil falls after Morgan Stanley downgrades rating to equal weight

Morgan Stanley downgraded Rentokil to “equal weight” from “overweight” and trimmed its price target to 420p from 500p. Shares were down 2.4% at 297.1p, with the stock down 33.6% year-to-date.